Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program

ClinicalTrials.gov ID: NCT01281657

Public ClinicalTrials.gov record NCT01281657. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 8:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this observational study is to collect long-term data on safety and effectiveness of fingolimod, particularly including clinical disease and patient outcome related parameters such as relapse and disability, in patients who have participated in prior trials within the fingolimod clinical development program. Furthermore, this study explores the incidence of selected safety related outcomes of fingolimod treatment during follow-up visits within the context of routine medical practice.

Study identification

NCT ID
NCT01281657
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Novartis
Industry
Enrollment
64 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2011 (Type not available)
Primary completion
Jul 2012 (Actual)
Completion
Jul 2012 (Actual)
Last update posted
Sep 6, 2012

2011 – 2012

United States locations

U.S. sites
42
U.S. states
22
U.S. cities
39
Facility City State ZIP Site status
North Central Neurology Associates, PC Cullman Alabama 35058 —
The Research & Education Inst. of Alta Bates Summit Med. Grp Berkeley California 94705 —
Neuro-Therapeutics, Inc. Pasadena California 91105 —
University of California San Francisco San Francisco California 94117 —
Yale Multiple Sclerosis Center New Haven Connecticut 06510 —
Georgetown University/Lombardi Cancer Center Washington D.C. District of Columbia 20007 —
Sunrise Clinical Research, Inc. Hollywood Florida 33021 —
University of Florida Jacksonville Florida 32209 —
University of Miami Miami Florida 33136 —
Neurological Associates Pompano Beach Florida 33060 —
Neurology Clinical Research, Inc. Sunrise Florida 33351 —
AMO Corporation Tallahassee Florida 32308 —
MS Center of Vero Beach Vero Beach Florida 32960 —
South Suburban Neurology Flossmoor Illinois 60422 —
Neurologic Associates, LTD Palos Heights Illinois 60463 —
Mercy Ruan Neurology Clinic Res Ct. Des Moines Iowa 50314 —
University of Kansas Medical Center Kansas City Kansas 66160 —
Mid America Neuroscience Institute Lenexa Kansas 66214 —
University of Maryland Baltimore Maryland 21201 —
Johns Hopkins MS Center Baltimore Maryland 21287 —
Caritas St. Elizabeth's Hospital Boston Massachusetts 02135 —
Springfield Neurology Associates, LLC Springfield Massachusetts 01104 —
Spectrum Health Medical Group, Neurology Grand Rapids Michigan 49525 —
Saint Luke's Hospital Kansas City Missouri 64111 —
The MS Center for Innovation in Care St Louis Missouri 63131 —
University of New Mexico Health Science Center Albuquerque New Mexico 87131 —
Mount Sinai School of Medicine New York New York 10029 —
Island Neurological Associates Plainview New York 11803 —
SUNY - Stony Brook University Stony Brook New York 11794 —
University of Toledo Health Science Campus Toledo Ohio 43614 —
MS Center of Oklahoma Oklahoma City Oklahoma 73120 —
Neurological Associates of Tulsa, Inc Tulsa Oklahoma 74137 —
University of Pennsylvania Health System Philadelphia Pennsylvania 19104 —
Thomas Jerfferson University Hospital Philadelphia Pennsylvania 19107 —
Vanderbilt University Nashville Tennessee 37204 —
University of Texas Medical School Houston Texas 77030 —
Integra Clinical Research San Antonio Texas 78231 —
University of Virginia Health System Charlottesville Virginia 22903 —
Swedish Neuroscience Institute Seattle Washington 98122 —
Dean Foundation Madison Wisconsin 53715 —
University of Wisconsin Madison Madison Wisconsin 53792 —
St. Luke's Medical Center Milwaukee Wisconsin 53215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01281657, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 6, 2012 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01281657 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →